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Dengue fever is the most important arthropod-borne viral disease worldwide, affecting
50–100 million individuals annually. The clinical picture associated with acute dengue virus
(DENV) infections ranges from classical febrile illness to life-threatening disease.The innate
immunity is the first line of defense in the control of viral replication.This review will exam-
ine the particular role of natural killer (NK) cells in DENV infection. Over recent years, our
understanding of the interplay between NK cells and viral pathogenesis has improved
significantly. NK cells express an array of inhibitory and activating receptors that enable
them to detect infected targets while sparing normal cells, and to recruit adaptive immune
cells. To date, the exact mechanism by which NK cells may contribute to the control of
DENV infection remains elusive. Importantly, DENV has acquired mechanisms to evade
NK cell responses, further underlining the relevance of these cells in pathophysiology.
Hence, understanding how NK cells affect the outcome of DENV infection could benefit
the management of this acute disease.
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INTRODUCTION
Dengue virus (DENV) is the most widespread arbovirus world-
wide transmitted by mosquitoes of the Aedes genus and is respon-
sible for major outbreaks leading to serious health and econom-
ical problems (1). Approximately 500,000 DENV cases progress
to be a life-threatening disease each year causing up to 20,000
deaths (2). DENV is a member of the genus Flavivirus and is
divided into four different serotypes (DENV1–DENV4). Early
1970, Halstead and Simasthien (3) suggested that primary infec-
tion with one serotype of DENV only confers short-term partial
cross-protection against other serotypes. Furthermore, secondary
heterologous infections contribute to the development of severe
forms of dengue fever (DF) [dengue hemorrhagic fever (DHF)
and dengue shock syndrome (DSS)] (4).
The clinical picture of primary DENV infection includes fever,
headache, myalgia, arthralgia, and petechial rash. Patients rapidly
develop high viremia for up to 6 days after the onset of fever. The
rapid initiation of the hosts’ innate defense mechanisms might
be a limiting factor in the development of DENV infection. In
rare cases, patients may develop complications including plasma
leakage and coagulation disorders, which may lead to a fatal out-
come (5, 6). One of the most important questions in regards to
dengue pathogenesis is the identity of the cells that play a cru-
cial antiviral role during the innate immune response to DENV
at the earliest stages of infection (7). Natural killer (NK) cells
are a major component of the innate arm of the immune sys-
tem. Although NK cells hold an early and central role early after
number of viral infections, not only for viral containment but
also for timely and efficient induction of adaptive responses, their
role in the control of DENV infection is still poorly documented.
The observation in the late 1970s that viral infections induce NK
cell-mediated killing stimulated a frenzy of research focused on
evaluating the role of these cells in defense against several viral
infections and cancer. The clearest demonstration of this role
derives from the growing number of cases of NK cell deficiency.
Since the initial known case of a girl with multiple severe or dis-
seminated herpesvirus infections, about 40 other unrelated cases
have been described and were mainly associated with severe her-
pesvirus infections, and EBV- or HPV-related cancers (8). Major
progress has been achieved since, in several important fields related
to NK cells. NK cells represented a wonderful biological para-
dox in that they appeared fully competent to kill target cells and
yet were clearly self-tolerant. As such, NK cells were “armed”
but not dangerous. Scientists focused their attention on under-
standing how these potent killers were contained and controlled.
We now appreciate that a precise balance of inhibitory and acti-
vating signals mainly regulates the functional outcome of these
cells (9–11). A flood of information concerning multiple types of
negative receptors on NK cells was gathered. Many of these recep-
tors respond to stimulation by major histocompatibility complex
(MHC) class-I molecules expressed on the surface of target cells
and this is considered to be the predominant mechanism respon-
sible for NK cell tolerance to self. These inhibitory NK receptors
include ILT-2 and the CD94/NKG2A complex, which recognize
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HLA-G and HLA-E, respectively, whereas the inhibitory killer-
cell immunoglobulin-like receptors (KIRs) recognize polymor-
phic MHC class-I molecules; in particular: KIR2DL1/KIR2DL2
and KIR2DL3 bind group 2 (C2) and group 1 (C1) HLA-C alle-
les, respectively, while KIR3DL1 recognizes HLA-Bw4 epitopes
(12). Numerous studies have shown that these factors likely syn-
ergize to generate susceptibility or resistance to pathogens and
disease (12, 13). In patients from southern Brazil, the susceptibility
to DF is positively associated with the presence of KIR3DS1-
Bw4, KIR3DL1-Bw4, KIR2DL1-C2, and KIR2DS1-C2 genes, and
negatively associated with KIR2DL3-C1/C1 (14).
To destroy a target, NK cells also present several cell-surface
activating receptors such as: NKG2D, DNAX accessory molecule-
1 (DNAM-1), an adhesion molecule physically and functionally
associated to Lymphocyte function-associated antigen 1 (LFA-1),
and the natural cytotoxicity receptors (NCRs: NKp30, NKp44, and
NKp46) (15, 16). Simultaneous interactions of certain of these
activating receptors on NK cells with their specific ligands on the
target cells, lead to the integration of different signals including
the modulation of the cell-cycle, and together dictate the quality
and intensity of the effector NK cell response (17). The relative
contribution of each of the activating receptors to NK cytotoxic-
ity against target cells differs, indicating the existence of an array
of specific ligands that will be presented and their role in DENV
infection further developed by Beltrán and Lopez-Verges, under
the research topic “Protective Immune Response to Dengue Virus
Infection and Vaccines: perspectives from the field to the bench.”
In this mini-review, we focused on what is currently known
about the mounting of the NK cell response with its role in cyto-
toxicity and immunoregulation during DENV infection as well as
the mechanisms acquired by the virus to evade NK cell killing.
ACTIVATION OF NK CELLS AFTER DENV INFECTION
Very early after infection, interferon-alpha (IFN-α) is the main-
stay of host defenses. This type I, IFN, is a crucial mediator of the
antiviral response directly inhibiting viral replication and modu-
lating downstream immune responses to counteract viral spread
(18). Elevated IFN-α plasmatic levels are observed shortly after
onset of symptoms in children and adult DENV-infected patients
(19, 20). Recently, Gandini et al. (21) have shown that DENV2 effi-
ciently activated IFN-α production by plasmacytoid dendritic cells
(pDCs), which produced up to 1000-fold more IFN-α than other
cell types in response to virus exposure. The infected pDCs could
then decrease DENV infection of monocytes. The importance of
the IFN-α response is also illustrated by the increased lethality
of IFN-α/β receptor knockout mice when administered DENV2
by intraperitoneal injection (22). Although it was shown that the
in vitro pretreatment of cultured cells with IFN-α/β dramatically
reduces DENV replication, type I IFN has little effect on DENV
replication after viral replication has been established (23). Indeed,
DENV can reach high titers (<109 infectious doses per milliliter)
in humans despite the induction of high levels of circulating IFN-α
(19, 24). Therefore, it seems likely that DENV has evolved mecha-
nisms to counteract the IFN response, a characteristic that is shared
by many pathogenic viruses (25).
It has long been established that one of the main mechanisms
accounting for the efficacy of the type I IFNs is their ability to
activate NK functions (Figure 1); thus, they promote the accu-
mulation and/or survival of proliferating NK cells by the STAT1-
dependent induction of IL-15 secretion (26). This early activity of
NK cells may be important for clearing primary DENV infection.
In a sensitive mouse model, acute infection with DENV showed a
rapid increase of NK cell levels (27). A significant increase in the
frequency of NK cell circulation was also shown in patients who
developed an acute DF (28). In addition, patients with a mild DF
have elevated NK cell rates when compared to those with severe DF
(29). Interestingly however, levels of circulating MIP-1β are higher
in mild acute DF and are associated with higher NK cell frequencies
(30). To characterize the primary NK response to DENV infection
in mice, the phenotype of NK cells in the spleen was assessed by
flow cytometric analysis. Three days after infection, the DENV-
infected mice had twice as many NK cells than the mock-infected
mice, and more than 50% of these NK cells expressed the early
activation marker CD69, although only 5–10% of NK cells in the
mock-infected animals expressed CD69 (27). Concomitantly, NK
cells from DENV-infected patients display simultaneously high
levels of CD69, HLA-DR, and CD38 (28, 29). For example, a sig-
nificant increase in the percentage of CD69+-expressing NK cells
was observed in DENV-infected patients at the early and acute
phase of infection (days 1–5 with 29 vs. 13%), maintained at days
6–10 (24 vs. 18%), but decreased after 11 days (13 vs. 5%) (28).
Altogether, these observations support the concept that DENV
infection induces the selection and proliferation of a subset of
activated NK cells further reinforcing their potentially important
role during the early stages of the disease.
NK CELL FUNCTION IN THE PROTECTION AGAINST DENV
CYTOKINES PRODUCED BY ACTIVATED NK CELLS
Upon activation, NK cells may produce cytokines that favor the
complete elimination of the disease and the infectious agent dur-
ing the adaptive response, such as IFN-γ, TNF-α, G-CSF, and
GM-CSF, as well as chemokines, such as MIP-1α, MIP-1β, and
Rantes (31) (Figure 1). Numerous investigations have shown that
DENV-infected patients presented significantly elevated levels of
IFN-γ, G-CSF, and GM-CSF (20, 29, 32), whereas other reports
suggest that TNF-α elevation could be associated with disease
severity (33, 34). However, the results were obtained by measur-
ing cytokine levels in sera collected from DENV-infected patients,
and do not reveal which specific cells are activated and involved
in their production. To date, the role played by NK cells in the
production of these soluble factors is unknown. Deeper investiga-
tions will be necessary to precisely determine the implication of the
immune-regulation by NK cells during the acute DENV infection.
NK CELL AND THEIR RECEPTORS DURING DENV INFECTION
One of the most prominent functions of NK cells is the capacity to
lyse virus-infected cells. When the balance of inhibitory/activating
signals is in favor of activation, the engagement of activating recep-
tors on the surface of NK cells leads to directed exocytosis of
granules containing perforin and granzymes, which in turn elicit
the disruption of the target cell membrane and/or the activation of
apoptosis pathways within the infected cell (11). It has been shown
that activated NK cells are cytotoxic against DENV-infected cells
(35). Furthermore, a marker of cytotoxicity, the granule cytotoxic
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FIGURE 1 | Overview of the suggested NK cell features after acute and primary DENV infection.
T cell intracellular antigen TIA-1, as well as two adhesion mol-
ecules, CD44 and CD11a, both involved in NK cell migration
to various tissues and NK cytotoxicity, have been found to be
significantly elevated on NK cells collected from acutely infected
patients (28).
Hershkovitz et al. (36) have demonstrated the existence of a
direct protein–protein interaction between recombinant DENV
soluble envelope E protein and NKp44 (but not NKp30 or NKp46)
that could be involved in the triggering of cytolysis (Figure 1).
Using West Nile virus (WNV) like particles (VLPs) and WNV-
infected cells, they have shown that E–NKp44 interaction triggers
the secretion of cytotoxic granules contained in NK cells, the lysis
of target cells, and the increased production of IFN-γ suggesting
that flavivirus E proteins activate NK cytotoxic activity through
NKp44 engagement.
Overall our understanding of the mechanisms involved in the
cytolysis of target DENV-infected cells by NK cells is in its infancy.
The receptors and signaling pathways essential to this major func-
tion are yet to be clearly identified. Recent investigations focusing
on the various target ligands involved in the cytotoxic response
by Beltrán and Lopez-Verges, under the Research topic “Protective
Immune Response to Dengue Virus Infection and Vaccines: per-
spectives from the field to the bench” may bring some insight as to
these questions.
ACTIVATION OF NK CELLS BY ADCC RESPONSES DURING EARLY DENV
INFECTION
Antibody-dependent cell-mediated cytotoxicity (ADCC) is
another known mechanism by which NK cells recognize and lyse
antibody-coated target cells, through the engagement of antibody
binding to the Fc gamma receptor IIIA (CD16) (37). In an in vitro
model, Kurane et al. (35) reported that human blood NK cells
are cytotoxic against DENV-infected cells via direct cytolysis but
also via ADCC (Figure 1). Indeed, PBMC collected from a DENV-
infected patient successfully lysed DENV-infected cells that did
not express MHC class-I molecules, and lysis of infected cells was
significantly increased upon addition of anti-DENV1 and DENV2
monoclonal antibodies. The addition of sera from an individual
without DENV antibodies did not lead to an increase in lysis of
infected cells. More recently, García et al. (38) tested acute and con-
valescent patients’ sera for ADCC activity, differentiating mild and
severe forms of DF. ADCC activity was observed with acute sera
only in cases of DHF/DSS but not DF. However, using convales-
cent sera collected 1 year later, all samples induced ADCC activity.
This suggests that the development of ADCC activity during the
acute phase of the infection could be associated to the pathologi-
cal manifestations of the severe syndrome and that the systematic
development of ADCC activity after a primary infection, in con-
valescent patients could be associated with the development of
severe forms during a subsequent heterologous DENV infection.
However, other studies suggest a protective role for ADCC against
DENV secondary infections. Indeed, higher ADCC activities have
been associated with higher plasma neutralizing antibody levels
and lower viral loads during secondary infection but solely if the
patient was secondarily infected by DENV3 and not DENV2 (39).
Altogether, this data support a strong implication of ADCC
after DENV infection, however, careful investigations are needed
to determine its exact contribution both in the viral clearance dur-
ing the initial acute phase of this infection and DENV pathogenesis
in secondary infections.
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DENV EVASION OF NK CELLS
Co-existence of viruses and their infected hosts imposes an evolu-
tionary pressure on both the virus and the host’s immune system.
The host has developed an immune system able to attack viruses
and virally infected cells, and viruses have developed an array of
immune evasion mechanisms to escape being killed by the host’s
immune system (40, 41). A wide variety of viruses have devel-
oped mechanisms to evade the NK cell response, and among these
the flaviviruses are known to have developed particularly evolved
mechanisms to escape NK cell-mediated lysis. Many viruses evade
T-cells recognition by down-regulating MHC class-I restricted
antigen presentation, whereas flaviviruses induce their cell-surface
expression. This leaves infected cells less susceptible to NK lysing,
MHC class-I molecules being able to effectively engage NK cell
inhibitory receptors (11, 42, 43). Regarding DENV infection, a
number of studies have demonstrated that DENV replicon expres-
sion is sufficient to enhance membrane expression of MHC class-I
inducing a reduced susceptibility to NK lysis (42, 44). The way by
which DENV induces MHC class-I up-regulation on the surface
of infected cells has been associated with an activation of NF-κB,
independently of IFN and without an increased synthesis of MHC
class-I molecules (45). The exact mechanism(s) and especially the
viral components involved are still obscure yet several hypothe-
ses were proposed. The up-regulation of MHC class-I expression
could be the result of: (i) an increase in the supply of peptides to
the endoplasmic reticulum mediated by the transporter associated
with antigen processing (TAP) (46) (ii) the expression of DENV
non-structural protein(s) and/or viral RNA replication (44), and
(iii) the accumulation of uncleaved C-prM protein during viral
assembly (47).
The major biological consequence of DENV-induced MHC
class-I increase is a profound reduction of NK cell lysis as shown
in in vitro cytotoxicity assays (35, 44). Moreover, an aggregation of
MHC class-I molecules at the surface of infected cells seems to lead
to increased affinity with NK cell inhibitory receptors (44). Given
that the kinetics of DENV viremia coincide with the peak of NK
cell response, the modulation of MHC class-I expression may have
physiological relevance in counteracting host NK cell defense. It is
likely that there is a complex balance between DENV-induced acti-
vation of NK cells and subversion of NK killing by DENV-induced
MHC class-I expression on infected cells. An additional compo-
nent to take into account is the genetic background of the host
since KIRs/HLA molecules combinations play a crucial role in the
strength of NK cell inhibitory function (13), and this could clearly
play important role on DENV infection susceptibility, protection,
and severity.
These viral escape mechanisms certainly reflect evolutionary
pressure exerted by the host immune response on the pathogen
but also highlight the importance of NK cells in the defense against
DENV infection.
CONCLUSION
Overall, several lines of evidence converge to suggest that NK cells
are activated early during an acute DENV infection, and produce
major cytokines, such as IFN-γ, which participate in the con-
trol of the viral replication while promoting the development of
an efficient adaptive immune response. In the future, it will be
interesting to determine if and how DENV leaves an imprint on
the NK receptor repertoire possibly favoring cells with a strong
cytolytic potential, as previously shown, by us and other groups,
with several other viruses, including chikungunya virus, which is
yet an other arbovirus (48). Numerous studies have also shown
that DENV increases MHC class-I and adhesion molecule expres-
sion, allowing the virus to escape NK cell lysis. Whilst underlining
the importance of NK cells in DENV infection, these observations
must be interpreted with great caution. Due to the lack of extensive
phenotypic and functional studies in DENV-infected patients, we
cannot conclude in favor of a beneficial or a deleterious role of the
NK cells in the control and/or the evolution of the disease. Future
studies based on the depletion of NK cells in a relevant animal
model for DENV infection, will be able to unravel this fascinating
topic.
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